Skip to main content

Table 1 Patients' characteristics

From: Can Lokomat therapy with children and adolescents be improved? An adaptive clinical pilot trial comparing Guidance force, Path control, and FreeD

ID

Age (years)

Main diagnosis (GMFCS Level)

More impaired leg

Walking speed (km/h)

Daily life mobility aids

1

19

CP, bilateral ataxic (III)

right

2.2

Dorsal walking frame for longer distances

2

19

Hereditary spastic paraplegia

right

2.2

None

3

14

CP, bilateral ataxic (II)

left

2.0

Dorsal walking frame, ankle-foot orthoses

4

14

ABI a (unilateral paresis)

left

1.9

Foot-up orthosis

5

16

ABI a (unilateral spastic paresis)

left

2.0

None

6

19

CP, bilateral spastic (III)

right

2.0

Crutches, orthopedic shoes

7

13

CP, bilateral spastic (II)

left

2.0

Foot-up orthosis

8

15

MMC L3/L4

right

1.8

Crutches

9

16

CP, bilateral spastic (II)

right

1.8

Ankle-foot orthoses

10

16

CP, bilateral spastic (III)

left

1.9

Dorsal walking frame for longer distances, ankle-foot orthoses

11

14

CP, bilateral spastic (III)

right

2.1

Ankle-foot orthoses

12

20

ABI a (bilateral spastic paresis)

right

1.8

None

13

19

CP c, bilateral spastic (IV)

right

1.4

Wheelchair, ankle-foot orthoses

DROP-OUT

14

15

CP, unilateral spastic (I)

left

1.8

None

15

14

ABI a (unilateral spastic paresis)

left

1.8

None

16

12

ABI b (unilateral paresis)

left

2.1

None

  1. Abbreviations: CP cerebral palsy, GMFCS Gross Motor Function Classification System [38], MMC Meningomyelocele (spina bifida), ABI acquired brain injury, a= measurements more than 2.5 years after event, b= measurements 2 months after event. cID 13 was excluded because the measurements had to be stopped shortly after the beginning